Astellas Pharma Inc

ALPMY-O

Analysis and Opinions about ALPMY-O

Signal
Opinion
Expert
TOP PICK
TOP PICK
November 8, 2019
It has been a long time since they have held a Japanese company. They are near the end of their "patent cliff", when the share price is negatively impacted by patent protection ending. They specialize in new cancer drugs and have a lot of new patents coming forward. Japan and healthcare shares are improving. Yield 2.17% (Analysts’ price target is $19.40)
Show full opinionHide full opinion
It has been a long time since they have held a Japanese company. They are near the end of their "patent cliff", when the share price is negatively impacted by patent protection ending. They specialize in new cancer drugs and have a lot of new patents coming forward. Japan and healthcare shares are improving. Yield 2.17% (Analysts’ price target is $19.40)
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Astellas Pharma Inc(ALPMY-O) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Astellas Pharma Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Astellas Pharma Inc(ALPMY-O) Frequently Asked Questions

What is Astellas Pharma Inc stock symbol?

Astellas Pharma Inc is a OTC stock, trading under the symbol ALPMY-O on the (). It is usually referred to as or ALPMY-O

Is Astellas Pharma Inc a buy or a sell?

In the last year, there was no coverage of Astellas Pharma Inc published on Stockchase.

Is Astellas Pharma Inc a good investment or a top pick?

Astellas Pharma Inc was recommended as a Top Pick by Norman Levine on 2019-11-08. Read the latest stock experts ratings for Astellas Pharma Inc.

Why is Astellas Pharma Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Astellas Pharma Inc worth watching?

In the last year, there was no coverage of Astellas Pharma Inc published on Stockchase.

What is Astellas Pharma Inc stock price?

On , Astellas Pharma Inc (ALPMY-O) stock closed at a price of $.